Catheter Stabilization Device Market Size is expected to grow significantly from 2022 to 2028 due to strong demand for minimally invasive surgeries. Besides, the need to minimize catheter-linked infections & complications will boost the industry growth.
A catheter stabilization device is used to secure an indwelling urinary catheter to prevent urethral trauma. The device may help minimize the risk of problems that can be caused by using an unsecured catheter. The catheter stabilization devices prevent accidental and unintentional urinary catheter extraction, thereby avoiding damage to the bladder. Considering the reduced hospitalization time, industry participants are likely to invest in advanced devices.
Based on the product, global catheter stabilization device market share from arterial securement devices will grow owing to an increasing number of surgeries linked with cancer therapies and cardiovascular diseases. Similarly, the demand for better surgical procedures has further escalated the need for catheter stabilization devices. Leading companies are likely to invest in arterial securements which have gained traction across hospitals and clinics.
In terms of end-users, hospitals could garner a considerable share of catheter stabilization device market over 2022-2028. With the rise in hospital-acquired infections, stakeholders are projected to invest in hospital infrastructure. According to the U.S. CDC, around 75% of urinary tract infections acquired in hospitals are linked with a urinary catheter. A notable surge in hospitalized patients receiving urinary catheters will augur well for the business outlook.
North America catheter stabilization device market share will expand on the back of the demand for cardiovascular-, urological- and respiratory procedures. Adoption of the device in diagnosis, examination and treatment will encourage manufacturers to ramp up the production. Moreover, a massive number of overseas patients prefer higher surgical procedures in the U.S. and Canada, which will reshape the industry outlook.
Market share is propelled with the presence of leading companies gearing to gain a competitive edge. M.C. Johnson Company, Inc., B. Braun, TIDI Products, LLC, Smith Group, Merit Medical Systems, C. R. Bard, Inc., Centurion Medical Products, 3M Company, Baxter International, Inc. and ConvaTec Inc., are some of the major companies in the landscape. The competitive landscape suggests they could emphasize on tactics such as mergers & acquisitions, R&D activities, technological advancements, innovations and product launches.
In September 2021, Smith Group announced the acquisition of its Smiths Medical division by ICU Medical. It would help ICU Medical to bolster its global reach with the expansion of syringe and ambulatory infusion devices, vital care and vascular access products.
The COVID-19 pandemic led to a surge in respiratory and cardiovascular procedures, prompting industry players to boost the production of fixation devices. Hospitals and diagnostic centers are poised to witness strong demand for catheter stabilization devices. Prominently, North America and Europe will continue to exhibit the demand for chest drainage tubes and central venous catheter securement devices. With favorable government policies and a surge in healthcare budgets, market forecast will be strong by 2028.
A surge in chronic lifestyle diseases, along with rising accidental cases, will expedite the adoption of catheter retaining devices. Besides, the demand for minimally invasive procedures will foster the need for catheter stabilization equipment.
Market, By Product
Market, By Application
Market, By End-user
The above information is provided for the following regions and countries: